Volume 6, Issue 3 (9-2016)                   Iran J Ped Hematol Oncol 2016, 6(3): 166-171 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Goudarzipour K, Eshghi P, Tara Z, Afjeh A, Farid S, Shiravi M. Prevalence of Microcytosis in Cord Blood Samples and Admitted Neonates in Tehran, Iran . Iran J Ped Hematol Oncol 2016; 6 (3) :166-171
URL: http://ijpho.ssu.ac.ir/article-1-260-en.html
Pediatric Congenital Hematologic Disorders Research Center, ShahidBeheshti University of Medical Sciences, Tehran, Iran
Abstract:   (5172 Views)

Abstract

Background: The study was established to define the prevalence of neonatal microcytosis and to estimate the incidence rate of alpha-thalassemia as its leading cause, in Tehran, Iran.

Materials and Methods: Overall, 800 neonates were selected from two populations of newborns and admitted neonates. Three hundred and sixty-one cord blood samples were obtained from deliveries in Mahdieh Hospital in April and May 2013. A second group of 439 neonates aged 1-5 days were subject to the study from admissions to the neonatal ward and neonatal intensive care units in Mahdieh Hospital between March 2011 and August 2014. All the included neonates were term, single, with normal birth weights. The admitted neonates suspected to have hemolytic anemia were excluded from the study. Microcytosis cut-off point was set at 95 fl.

Results: Prevalence of microcytosis was 2.5% in cord blood samples and 7.7% in admitted neonates. The admitted neonates showed a 3.28-fold higher risk of microcytosis compared to newborns. The average mean corpuscular volume was 104.6 ± 4.5  fl in newborns and 103.2 ± 6.0 fl in the admitted neonates. The admitted neonates had smaller and lower numbers of erythrocytes with higher mean corpuscular hemoglobin.

Conclusion: Prevalence of neonatal microcytosis was lower than expected in healthy newborns based on some previous studies, and therefore, alpha-thalassemia carriership as the main leading cause of neonatal microcytosis does not appear to be an urgent issue for mass screening to be considered. Selective screening should be taken into account as a more cost-effective option in neonatology wards.

Full-Text [PDF 152 kb]   (1517 Downloads)    
Type of Study: Research | Subject: Heart
Received: 2015/12/8 | Accepted: 2016/04/19 | Published: 2016/09/3

References
1. Harteveld CL, Higgs DR. Alpha-thalassaemia. Orphanet J Rare Dis. 2010; 5: 13. [Article]
2. World Health Organization, March of Dimes. Management of birth defects and haemoglobin disorders: report of a joint WHO-March of Dimes meeting, Geneva, Switzerland, 17-19 May 2006. Geneva: World Health Organization; 2006. 27. [Article]
3. Hamamy HA, Al-Allawi NA. Epidemiological profile of common haemoglobinopathies in Arab countries. J Community Genet. 2013; 4(2): 147-67. [Article]
4. Alkindi S, Pathare A, Al-Madhani A, Al-Zadjali S, Al-Haddabi H, Al-Abri Q, et al. Neonatal Screening: Mean haemoglobin and red cell indices in cord blood from Omani neonates. Sultan Qaboos Univ Med J. 2011; 11(4): 462-9. [Article]
5. Charoenkwan P, Taweephol R, Sirichotiyakul S, Tantiprabha W, Sae-Tung R, Suanta S, et al. Cord blood screening for alpha-thalassemia and hemoglobin variants by isoelectric focusing in northern Thai neonates: correlation with genotypes and hematologic parameters. Blood Cells Mol Dis. 2010; 45(1): 53-7.
6. Tritipsombut J, Sanchaisuriya K, Fucharoen S, Fucharoen G, Siriratmanawong N, Pinmuang-ngam C, et al. Hemoglobin profiles and hematologic features of thalassemic newborns: application to screening of alpha-thalassemia 1 and hemoglobin E. Arch Pathol Lab Med. 2008; 132(11): 1739-45.
7. Harteveld CL, Yavarian M, Zorai A, Quakkelaar ED, van Delft P, Giordano PC. Molecular spectrum of alpha-thalassemia in the Iranian population of Hormozgan: three novel point mutation defects. Am J Hematol. 2003; 74(2): 99-103.
8. Bahrami R, Pishva N, Shahriari M, Naghshzan A. Prevalence and Assessment of the Appropriate Labratory Indices for Screening of Hemoglobinopathies in Southern Iranian Newborns. Iranian Journal of Neonatology. 2012; 3(2): 63-8. [Article]
9. Jalali H, Mahdavi MR, Roshan P, Kosaryan M, Karami H, Mahdavi M. Alpha thalassemia gene mutations in neonates from Mazandaran, Iran, 2012. Hematology. 2014; 19(4): 192-5. [Article]
10. Mahdavi MR, Kowsarian M, Karami H, Mohseni A, Vahidshahi K, Roshan P, et al. Prevalence of hemoglobin alpha-chain gene deletion in neonates in North of Iran.Eur Rev Med Pharmacol Sci. 2010; 14(10): 871-5. [Article]

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Iranian Journal of Pediatric Hematology and Oncology

Designed & Developed by : Yektaweb